PCa cells are characterized by overexpression of prostate-specific membrane antigen (PSMA), a transmembrane glycoprotein, whose levels are correlated with disease progression, making it a favorable diagnostic and therapeutic tool in mCRPC [10]. This evidence concerns the gene FOLH1 and posterior cortical atrophy.